Book Profiles 32 Women Who Fought Breast Cancer

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 10
Volume 5
Issue 10

BIRMINGHAM, Ala--In 1994, the Comprehensive Cancer Center of the University of Alabama at Birmingham commissioned photojournalist Melissa Springer to create an exhibit celebrating breast cancer survivors. Her finished project has now been published as A Tribe of Warrior Women.

BIRMINGHAM, Ala--In 1994, the Comprehensive Cancer Center of theUniversity of Alabama at Birmingham commissioned photojournalistMelissa Springer to create an exhibit celebrating breast cancersurvivors. Her finished project has now been published as ATribe of Warrior Women.

The book is intended to promote national awareness that breastcancer is a treatable disease fought best by early detection andtreatment; to pay tribute to all women who have fought so courageouslyagainst breast cancer; and to inspire hope in newly diagnosedwomen.

With that mission in mind, each of the 32 breast cancer survivorsprofiled in the book was asked to give some words of comfort tonewly diagnosed women.

Bessie McClinton, featured on the book's cover (see illustrationabove), responded, "Wherever you're going, wherever you'vebeen, I've already been there," and many others picked upon that theme, with messages such as, "Fight like hell andknow that you're not alone," "Find a support group,"and "I was in your shoes years ago. I fought and won."

Other women stressed the importance of treatment: "Get agood doctor and a good hospital." "Understand the treatmentoptions. Make an informed decision." "Don't let fearparalyze you."

The book is available from Crane Hill Publishers. A portion ofthe proceeds will be donated to The Breast Cancer Research Foundationof Alabama.

Recent Videos
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
Multidisciplinary care can help ensure that treatment planning does not deviate from established guidelines for inflammatory breast cancer management.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content